Recursion Pharmaceuticals, Inc.
RXRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$464 | -$328 | -$239 | -$186 |
| Dep. & Amort. | $36 | $24 | $12 | $8 |
| Deferred Tax | $0 | $0 | $0 | $1 |
| Stock-Based Comp. | $82 | $54 | $28 | $15 |
| Change in WC | -$38 | -$50 | $105 | -$0 |
| Other Non-Cash | $24 | $13 | $11 | $4 |
| Operating Cash Flow | -$359 | -$288 | -$84 | -$159 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$14 | -$12 | -$37 | -$40 |
| Net Acquisitions | $277 | $2 | $0 | $232 |
| Inv. Purchases | $0 | $0 | $0 | -$301 |
| Inv. Sales/Matur. | $0 | $0 | $231 | $69 |
| Other Inv. Act. | -$3 | -$1 | -$0 | -$232 |
| Investing Cash Flow | $260 | -$10 | $193 | -$272 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$4 | -$1 | -$0 | -$13 |
| Stock Issued | $300 | $128 | $144 | $463 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $8 | $13 | $11 | $8 |
| Financing Cash Flow | $304 | $140 | $154 | $459 |
| Forex Effect | -$3 | $0 | -$0 | $0 |
| Net Chg. in Cash | $202 | -$158 | $264 | $28 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $401 | $559 | $295 | $267 |
| End Cash | $603 | $401 | $559 | $295 |
| Free Cash Flow | -$373 | -$300 | -$121 | -$198 |